RK
Reshma Kewalramani sold $6.3M of VRTX stock
Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc / Ma (VRTX), sold 11,866 shares of VRTX stock worth $6.3M, per an SEC Form 4 filed Nov 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 6, 2026, 4 days before it was made public.
VRTX has moved -0.8% since the trade date, from $547.09 to $542.62 (Nov 12, 2026 close).
- Traded
- Nov 6, 2026
- Disclosed
- Nov 10, 2026
- Filing delay
- 4 days
- Price since
- -0.8%
- Role
- CEO & President
- Source
- SEC Form 4